1. Home
  2. HALO vs LSCC Comparison

HALO vs LSCC Comparison

Compare HALO & LSCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HALO
  • LSCC
  • Stock Information
  • Founded
  • HALO 1998
  • LSCC 1983
  • Country
  • HALO United States
  • LSCC United States
  • Employees
  • HALO N/A
  • LSCC N/A
  • Industry
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • LSCC Semiconductors
  • Sector
  • HALO Health Care
  • LSCC Technology
  • Exchange
  • HALO Nasdaq
  • LSCC Nasdaq
  • Market Cap
  • HALO 7.6B
  • LSCC 6.9B
  • IPO Year
  • HALO N/A
  • LSCC 1989
  • Fundamental
  • Price
  • HALO $76.90
  • LSCC $64.41
  • Analyst Decision
  • HALO Buy
  • LSCC Strong Buy
  • Analyst Count
  • HALO 8
  • LSCC 10
  • Target Price
  • HALO $70.25
  • LSCC $66.10
  • AVG Volume (30 Days)
  • HALO 2.0M
  • LSCC 2.1M
  • Earning Date
  • HALO 10-30-2025
  • LSCC 11-03-2025
  • Dividend Yield
  • HALO N/A
  • LSCC N/A
  • EPS Growth
  • HALO 68.93
  • LSCC N/A
  • EPS
  • HALO 4.37
  • LSCC 0.23
  • Revenue
  • HALO $1,178,672,000.00
  • LSCC $488,631,000.00
  • Revenue This Year
  • HALO $32.57
  • LSCC $3.92
  • Revenue Next Year
  • HALO $23.25
  • LSCC $19.45
  • P/E Ratio
  • HALO $17.65
  • LSCC $280.96
  • Revenue Growth
  • HALO 34.97
  • LSCC N/A
  • 52 Week Low
  • HALO $42.01
  • LSCC $34.69
  • 52 Week High
  • HALO $77.60
  • LSCC $70.55
  • Technical
  • Relative Strength Index (RSI)
  • HALO 77.94
  • LSCC 55.28
  • Support Level
  • HALO $74.52
  • LSCC $64.62
  • Resistance Level
  • HALO $76.28
  • LSCC $67.65
  • Average True Range (ATR)
  • HALO 1.63
  • LSCC 1.82
  • MACD
  • HALO -0.06
  • LSCC -0.51
  • Stochastic Oscillator
  • HALO 88.60
  • LSCC 22.86

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About LSCC Lattice Semiconductor Corporation

Lattice Semiconductor Corp is a developer of semiconductor technology that it distributes through products, solutions, and licenses. The company reaches its customers through consumer, communications, and industrial markets. The company has one operating segment namely the core Lattice business that includes silicon-based and silicon-enabling products, evaluation boards, development hardware, and related intellectual property licensing, services, and sales. The products of the company are offered globally; and, the majority of sales are derived from customers in Asia. It also has its presence in Americas and Europe.

Share on Social Networks: